UARS Treatment

Upper airway resistance syndrome (UARS) is a condition that was first identified and described at Stanford University. It is similar to obstructive sleep apnea (OSA) in that the soft tissue of the throat relaxes and reduces the size of the airway, resulting in disturbed sleep and consequent daytime impairment, including excessive daytime sleepiness.

Although the increase in upper airway resistance is not enough to meet criteria of the sleep disordered breathing that defines obstructive sleep apnea, the resulting increase in breathing effort does cause a brief awakening from sleep that is often undetected by the affected individual. When this scenario repeats through the night, sleep is impaired, just like in obstructive sleep apnea.

Some patients who have sleep tests completed are told they do not have sleep apnea, but these patients may very well have UARS. This can be just as dangerous since UARS prevents proper sleep cycles. It involves numerous awakenings or arousals that make it difficult to reach deep sleep and REM sleep which is vital for proper health. Without the restorative stages of sleep, people begin to feel tired, lack energy, and may develop comorbidities.
Our devices have shown to reduce upper airway resistance by decreasing inflammation, reducing turbinate size, and even reducing polyps and polypoid tissue in the nasal passages and sinuses